Users praised the FDA clinical trial reforms for leveraging America's technological edge to protect biomedical innovation from China's brute force drug development approach.
No Digg Deeper questions have been answered for this story yet.
Unless the US reforms its drug development ecosystem, it risks surrendering leadership. Other nations have no intrinsic scientific edge, nor will they fully replicate the US network of VC, start-ups, and academic research that fuels our discovery engine.
https://www.statnews.com/2026/06/22/fda-speed-up-early-stage-single-study-clinical-trials/
... China often takes a brute force approach to drug development. America’s strength lies in its technological edge. Protecting the intellectual space around biomedical invention isn’t merely a commercial or legal chore; it preserves the engine that drives our public health...